112 results match your criteria: "Chongqing University FuLing Hospital[Affiliation]"
Sci Rep
December 2024
Department of Cardiovascular Medicine, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Avenue, Nan'an District, Chongqing, 400072, China.
The Platelet-to-Lymphocyte Ratio (PLR) has emerged as a cost-effective biomarker for systemic inflammation and adverse cardiovascular outcomes, yet its prognostic value in critically ill patients with heart failure (HF) remains unclear. Leveraging the MIMIC-IV database, this study investigates the association between PLR and 1-year all-cause mortality in 7,217 ICU patients with HF. Patients were stratified into tertiles (0-126.
View Article and Find Full Text PDFFront Genet
December 2024
Department of Burn and Plastic Surgery, Chongqing University Fuling Hospital, Chongqing University, Chongqing, China.
[This corrects the article DOI: 10.3389/fgene.2024.
View Article and Find Full Text PDFACS Omega
December 2024
Department of Ultrasound, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Telomerase activation can lead to the escape from cell senescence and immortalization, playing a crucial role in the growth and proliferation of cancer cells. Therefore, the detection of telomerase activity is essential for cancer diagnosis and treatment. Herein, we develop a novel ultrasensitive and visually detectable platform.
View Article and Find Full Text PDFAccumulation of free α-globin is a critical factor in the pathogenesis of β-thalassemia. Autophagy plays a crucial role in clearing toxic free α-globin, thereby reducing disease severity. However, the impact of natural mutations in autophagy-related genes (ATGs) on the phenotypic variability of β-thalassemia remains unclear.
View Article and Find Full Text PDFJ Mol Histol
December 2024
The Comprehensive Cancer Center, Chongqing University Fuling Hospital, No.2 Gaosuntang Road, Fuling District, 408000, Chongqing, P.R. China.
Background: Breast cancer (BC) poses a significant global health challenge, with chemotherapy resistance, especially to docetaxel, remaining a major obstacle in effective treatment. The molecular mechanisms underlying this resistance are critical for developing targeted therapeutic strategies.
Objective: This study aims to explore the role of dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2), a member of the DYRK family, in docetaxel resistance in breast cancer cells and investigate its impact on cellular responses, including drug sensitivity and migration.
EClinicalMedicine
December 2024
School of Mathematical Sciences, Zhejiang University, Zijingang Campus, Hangzhou, Zhejiang, China.
Front Nutr
November 2024
Department of Gastrointestinal Surgery, Chongqing University FuLing Hospital, Chongqing, China.
Stem Cell Res Ther
December 2024
Department of Hematology Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
Background: Acute myeloid leukemia (AML) is characterized by abundant immature myeloid cells, relapse and refractory due to leukemia stem cells (LSCs). Bone marrow mesenchymal stem/ stromal cells (BMSCs) supported LSCs survival, meanwhile, chemotherapy improved connexin43 (CX43) expression. CX43, as the most intercellular gap junction, facilitated transmit mitochondria from BMSCs into AML.
View Article and Find Full Text PDFAnalyst
December 2024
Central Laboratory, Chongqing University FuLing Hospital, Chongqing, 408099, China.
Cardiovascular disease, intimately linked to dyslipidemia, is one of the leading global causes of mortality. Dyslipidaemia often presents as an elevated concentration of low-density lipoprotein (LDL) and a decreased concentration of high-density lipoprotein (HDL). Therefore, accurately measuring the levels of LDL and HDL particles is crucial for assessing the risk of developing cardiovascular diseases.
View Article and Find Full Text PDFDiagnostics (Basel)
November 2024
Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Front Immunol
November 2024
Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China.
Predicting prognosis in lung cancer patients is important in establishing future treatment and monitoring plans. Lung adenocarcinoma (LUAD) is the most common and aggressive type of lung cancer with dismal prognosis and prognostic stratification would help to guide treatment. Aberrant DNA methylation in tumors occurs earlier than clinical variations, and keeps accumulating as cancer progresses.
View Article and Find Full Text PDFMol Med
November 2024
Department of Pathology, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, China.
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma which possess highly aggressive and heterogeneous. Despite advances in understanding heterogeneity and development of novel targeted agents, the prognosis of DLBCL patients remains unsatisfied. Lipids are crucial components of biological membranes and signal transduction while accumulating evidence has supported the vital roles of abnormal lipid metabolism in tumorigenesis.
View Article and Find Full Text PDFAnal Biochem
February 2025
Department of Gastroenterology, Chongqing People's Hospital, Chongqing, 401147, China. Electronic address:
There is an urgent demand for a simple yet extremely accurate biosensor to analyze tumorigenesis. Herein, we present a novel fluorescent and enzyme-free approach for detecting p53 gene cascading proximity ligation-mediated catalytic hairpin assembly and DNAzyme-assisted signal reaction. When the target p53 gene is present, the interaction between p53 and L1 and L2 chains initiates catalytic hairpin assembly and subsequently exposes DNAzyme in the P3 probe.
View Article and Find Full Text PDFInsights Imaging
October 2024
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
J Transl Med
October 2024
Department of Nuclear Medicine, Chongqing University FuLing Hospital, Chongqing University, No. 2 Gaosuntang Road, Chongqing, China.
Gastrointestinal tumors are the main causes of death among the patients. These tumors are mainly diagnosed in the advanced stages and their response to therapy is unfavorable. In spite of the development of conventional therapeutics including surgery, chemotherapy, radiotherapy and immunotherapy, the treatment of these tumors is still challenging.
View Article and Find Full Text PDFSci Rep
October 2024
Zigong Fourth People's Hospital, Sichuan Province, Zigong, China.
To investigate the status of dignity impairment symptoms in critically ill patients after ICU treatment and conduct a systematic analysis of its influencing factors, aiming to provide reference for clinical medical decision-making by healthcare professionals. A cross-sectional survey study. From April 15th to 21st, 2024, a cross-sectional survey was conducted in 40 tertiary Grade A comprehensive hospitals in 9 provinces, municipalities, and autonomous regions including Sichuan Province, Zhejiang Province, and Chongqing Municipality.
View Article and Find Full Text PDFOncogene
November 2024
Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
J Med Case Rep
October 2024
Department of Endocrinology and Metabolism, Chongqing University Fuling Hospital, No. 2 Gaosuntang Road, Fuling, China.
Int J Med Inform
December 2024
Department of Hepatobiliary Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu 225001, China; Department of Hepatobiliary Surgery, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu 225001, China. Electronic address:
Biomark Res
September 2024
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical Universityand, Shandong Academy of Medical Sciences , Jinan, China.
World J Emerg Med
January 2024
Emergency Department, Sichuan Academy of Medical Sciences/Sichuan Provincial People's Hospital, Chengdu 610072, China.
Int J Surg
September 2024
Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
J Fluoresc
August 2024
College of Pharmacy, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
Curr Med Imaging
August 2024
Department of Medical Imaging, Chongqing University Fuling Hospital, Chongqing, China.